Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Dec 15;14(12):8788-8792.
eCollection 2022.

Malignant adenomyoepithelioma of the breast: cases report and literature review

Dandan Wang  1 , Jian Zhang  1 , Linhong Jiang  2 , Xiu Chen  1 , Sujin Yang  1 , Junchen Hou  1 , Qian Zhang  1 , Jinhai Tang  1 , Lei Li  1 , Heda Zhang  1
Affiliations
Case Reports

Malignant adenomyoepithelioma of the breast: cases report and literature review

Dandan Wang et al. Am J Transl Res. .

Abstract

Background: Malignant adenomyoepithelioma (MAME) of the breast is an extremely rare breast malignancy, in which they arise from either luminal epithelial or myoepithelial components, or both. At present, there is very little clinical data of MAME.

Case report: We present two cases, one of them is a 34-year-old woman who underwent needle biopsy for a 3.2 cm-size mass in the right breast, and the pathology was MAME of breast. Another case is a 45-year-old woman who had a 3.0 cm-size mass in the right breast. We performed a breast-conserving surgery and sentinel lymph node biopsy, both of which were negative. The histopathology of these two cases was invasive carcinoma; however, these cases were eligible for MAME of the breast through combining with immunohistochemistry.

Conclusions: MAME of the breast is very rare, and has a diverse cell morphology, which must be combined with immunohistochemistry to make a clear diagnosis. Besides, it should be differentiated from adenoid cystic cancer, malignant leafy tumor, spindle cell carcinoma, etc. The clinical characteristics and treatment strategies were further discussed in combination with the literature.

Keywords: CK; Malignant adenomyoepithelioma; breast; immunohistochemistry.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
Imaging and pathological examinations in Case 1. A, B: Breast magnetic resonance imaging showed an upper inner mass in the right breast. C: Mammary ultrasound revealed a low echoic mass. D. Pathologic finding (H&E stain) (100 × magnification).
Figure 2
Figure 2
Imaging and pathological examinations in Case 2. A, B: Breast magnetic resonance imaging showed an upper outer mass on the edge of the gland in the right breast. C: Mammary ultrasound revealed a low echoic mass. D. Pathologic finding (H&E stain) (100× magnification).
See this image and copyright information in PMC

References

    1. Hamperl H. The myothelia (myoepithelial cells). Normal state; regressive changes; hyperplasia; tumors. Curr Top Pathol. 1970;53:161–220. - PubMed
    1. Tan PH, Ellis IO. Myoepithelial and epithelial-myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO Classification of Tumours of the Breast 2012. J Clin Pathol. 2013;66:465–470. - PubMed
    1. Zhai DY, Zhen TT, Zhang XL, Luo J, Shi HJ, Shi YW, Shao N. Malignant adenomyoepithelioma of the breast: two case reports and review of the literature. World J Clin Cases. 2021;9:9549–9556. - PMC - PubMed
    1. Muller KE, Marotti JD. Genotype-phenotype associations in breast pathology: achievements of the past quarter century. Breast J. 2020;26:1123–1131. - PubMed
    1. Kihara M, Yokomise H, Irie A, Kobayashi S, Kushida Y, Yamauchi A. Malignant adenomyoepithelioma of the breast with lung metastases: report of a case. Surg Today. 2001;31:899–903. - PubMed

Publication types

LinkOut - more resources